HHS Reopened the Wireless Radiation Record After Seven Years of Silence. Researchers Have Until October 21 to Say What Should Be Funded.

On September 21, 2026, the Department of Health and Human Services published a Request for Information in the Federal Register on radiofrequency and electromagnetic field exposure and human health. The docket is HHS-OASH-2026-0397, it came out of the Office of the Assistant Secretary for Health, it was signed by Secretary Robert F. Kennedy Jr., and comments are due October 21, 2026.

One day later, on September 22, the Federal Communications Commission opened its own proceeding on RF exposure issues, with comments due October 22, 2026.

Two federal agencies, two dockets, twenty-four hours apart, on a question neither has formally moved on in years. For anyone who builds a research portfolio in environmental health, exposure science, epidemiology, dosimetry, or biophysics, this is not a news item. It is a thirty-day window in which the federal government is explicitly asking which research gaps it should be funding — and the answer it receives will shape what notices of funding opportunity exist, or do not exist, in this field for the next several years.

What HHS is asking

The RFI is broad by design. HHS solicits input from "individuals, families, caregivers, healthcare professionals, public health practitioners, researchers, organizations, equipment or product manufacturers, service or infrastructure providers, and other interested stakeholders" with knowledge or experience of RF/EMF emission and exposure. It poses seventeen questions.

The substantive clusters, as published:

• Evidence of effects at levels below current federal exposure limits. This is the question that matters most, because current US limits are built on an acute thermal-effects model. Any finding below those limits is, by construction, a finding the regulatory framework does not account for.
• Evidence of effects caused by current exposure limits — that is, whether the limits themselves are the source of exposure-related harm as implemented.
• Cumulative and aggregate exposure across the full modern stack: 5G, Wi-Fi, satellite communications, smart meters, and wireless medical devices. Legacy exposure assessment was built around a single phone held against a head. The question is what total body burden looks like when exposure is ambient, continuous, and multi-source.
• Exposure measurement and standards adequacy — metrology, personal dosimetry, and whether the standards infrastructure can measure what it purports to limit.
• Potentially sensitive populations — children, pregnant people, people with implanted devices, occupationally exposed workers.
• Health experiences, which HHS explicitly invites from non-researchers.
• And the one that is functionally a funding question: the highest-priority research gaps regarding EMF and RF radiation and public health that the federal health agencies should address.

Kennedy's framing in the announcement was explicit about the purpose: "I encourage scientists, physicians, industry, public health experts, workers, parents, and citizens to bring us the best available evidence so we can identify the gaps and focus federal research where it is needed most."

An agency head saying "focus federal research where it is needed most" in a docket notice is, in practical terms, an invitation to write the justification section of a future program announcement.

Why there is a gap to fill

The reason this RFI is consequential rather than routine is that the federal research infrastructure in this area was largely dismantled after producing a finding nobody fully resolved.

The National Toxicology Program ran a rodent carcinogenicity study of cell-phone RF radiation that cost roughly $30 million over about ten years and reported what NTP characterized as clear evidence of an association with tumors in exposed male rats. It was, at the time, the largest animal study of its kind. NTP then did not pursue the follow-up research program the finding implied, and the program has since stepped away from the area. NIEHS — which sits inside HHS — previously supported EMF/RF research infrastructure that has largely closed.

So the current state is: a large, expensive, government-run study produced a positive signal; the government did not fund the mechanistic, dosimetric, and epidemiological work that would have told us what the signal meant; and the capacity to do that work atrophied. That is precisely the shape of a situation in which an RFI asking "what are the highest-priority gaps" has real downstream consequences, because the honest answer is that most of the gaps are the ones created by stopping.

On the regulatory side, the history is equally static. The FCC opened a Notice of Inquiry in 2013 asking whether its RF exposure limits needed updating. It closed that inquiry in 2019 without changing the limits. In 2021, the D.C. Circuit held that the closure was arbitrary and capricious because the Commission had not given a reasoned explanation addressing the scientific evidence in the record, and remanded. The Commission then did not substantively act for several years. Its September 2026 notice is the first serious movement on that remand.

Seven years from the 2019 closure. Five years from the court's remand. Both agencies moving in the same week is not coincidence; it is a backlog clearing.

The two dockets want different things — do not send the same comment to both

This is the single most important tactical point, and the agencies have been unusually clear about it.

The FCC has signaled that it prioritizes submissions from "local, state, federal, and international health and safety agencies" and scientific standard-setting organizations, and has actively discouraged voluminous public testimonials. The FCC's question is regulatory: are the numerical exposure limits correct, and what record supports changing or retaining them? A comment to the FCC should be about limits, dosimetry, standard-setting bodies, and the adequacy of the record on remand.

HHS has done the opposite. It explicitly welcomes individuals, families, and caregivers describing personal health experiences they believe are associated with RF/EMF exposure. HHS's question is a public-health and research-priority question, not a rulemaking on numerical limits.

If you are a researcher, the implication is direct: your comment is worth more in the HHS docket than you might assume, and worth more in the FCC docket than almost anyone else's. The FCC has pre-announced that it will weight agency and standards-body input heavily and discount volume. In a docket where the public is expected to arrive in large numbers and the agency has said in advance that volume will not move it, a technically specific submission from someone who can characterize a study design is disproportionately influential.

The inverse risk is also real and worth naming plainly. This is a contested field with energetic advocacy on multiple sides. A comment record dominated by testimonials — however sincere — makes it easier for an agency to later characterize the record as non-scientific and conclude that no change is warranted. That is almost certainly why the FCC wrote its prioritization language the way it did. Researchers who want the record to support a funding program have to put the fundable science into it themselves.

How to write a comment that becomes a funding opportunity

RFIs convert into money through a specific mechanism: agency staff drafting a future program announcement need a justification section, and they build it from the docket. A comment that only asserts a conclusion gives them nothing to cite. A comment that specifies a study gives them a paragraph.

Name the gap in the agency's own words. HHS asked for "highest priority research gaps." Use that phrase and answer it as a ranked list, not as an essay. Three gaps, ordered, with one paragraph each.

Specify a design, not a position. For each gap, state the population, the exposure metric and how it would be measured, the endpoint, the comparison, and the approximate scale. "Children's cumulative ambient exposure is unmeasured" is not fundable. "A prospective cohort of 2,000 children ages 5–12 with personal RF dosimetry at 1-minute resolution across home, school, and transit microenvironments, linked to neurodevelopmental assessment at 24 and 48 months" is a notice of funding opportunity with the serial numbers filed off.

Say what infrastructure is missing. This is the highest-leverage move available and almost nobody makes it. Programs get funded when an agency recognizes it cannot answer a question with existing capacity. Personal dosimetry instrumentation that works across 5G bands, exposure-assessment reference materials, a shared biorepository, an animal-model facility to replicate the NTP finding at lower intensities — these are capacity gaps, and capacity gaps are what RFI-driven programs usually buy first. Note that NIST and NIBIB are simultaneously building a joint medical metrology and standards roadmap through their own RFI, docket NIST-2026-0133, which closes November 30; exposure-measurement capacity arguments have two live venues this fall.

Engage the NTP finding directly and honestly. The $30 million study is the central fact in this record. Whatever you think it showed, a comment that explains what follow-up design would resolve its interpretation — replication at lower specific absorption rates, modern modulation schemes, mechanistic work, or a definitive null — is addressing the actual open question rather than relitigating it. Agencies fund resolution, not argument.

Do not overclaim. The credibility of a research comment in a docket like this is its only asset. State what the evidence supports, state the uncertainty, and let the gap statement do the work. A comment that is visibly careful about what is unknown is the one a program officer can cite.

Dates

HHS comments go through Regulations.gov under docket HHS-OASH-2026-0397; the office also published OASH-RFI@hhs.gov as a contact. FCC comments go through the Commission's electronic filing system under the relevant docket number in its September 22 notice.

The realistic expectation

No RFI obligates anyone to spend anything. HHS can read seventeen questions' worth of responses and publish nothing. The FCC can satisfy the remand with a better-reasoned explanation and leave the limits where they are. Both outcomes are entirely plausible and would not be unusual.

But the asymmetry favors commenting. If the agencies do nothing, a comment cost you an afternoon. If HHS does build a research program — and an RFI that asks where to "focus federal research" is the standard first step toward one — then the people who put specific, fundable, well-characterized study designs into the record in October 2026 will find the eventual announcement describes work they can do, because they described it first.

That is how this mechanism actually works, and the window is twenty days.